Increased susceptibility of cord blood B lymphocytes to undergo spontaneous apoptosis

Clinical and Experimental Immunology

Volumn 145, Issue 3, 2006, Pages 563-570

  Kessel, A ^a   Yehudai, D ^a   Peri, R ^a   Pavlotzky, E ^a   Bamberger, E ^a   Tov, N ^a   Toubi, E ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

B cell apoptosis; BAFF; Cord blood; IL 4

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CD5 ANTIGEN; INTERLEUKIN 4; LIPOCORTIN 5; PROTEIN BCL 2; TUMOR NECROSIS FACTOR;

ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD19+ CD5+ B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SERUM; UMBILICAL CORD BLOOD;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD19; ANTIGENS, CD5; APOPTOSIS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELLS, CULTURED; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-4; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747384565     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03170.x     Document Type: Article

References (36)

1. Wu LYF, Blanco A, Cooper MD, Lawton AR. Ontogeny of B-lymphocyte differentiation induced by pokeweed mitogen. Clin Immunol Immunopathol 1976; 5:208-17.
2. Unander AM, Hammarstrom L, Smith CIE. Functional maturity of cord blood B lymphocytes: Staphylococcus aureus Cowan 1 induces IgG secretion in the human neonate. Clin Exp Immunol 1983; 53:703-8.
3. Miller KM, Pittard WB, Sorensen RU. Cord blood B cell differentiation. Synergistic effect of pokeweed mitogen and Staphylococcus aureus on in vitro differentiation of B cells from human neonates. Clin Exp Immunol 1984; 56:415-24.
4. Siegrist CA. Neonatal and early life vaccinology. Vaccine 1984; 14:3331-46.
5. Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today 1999; 20:312-16.
6. Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD, Herzenberg LA. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984; 81:2494-8.
7. Gagro A, McCloskey N, Challa A et al. CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40. Immunology 2000; 101:201-9.
8. Wurster AL, Rodgers VL, White MF, Rothstein TL, Grusby MJ. Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J Biol Chem 2002; 277:27169-75.
9. Schneider P, MacKay F, Steiner V et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999; 7:189 (11): 1747-56.
10. Shu HB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 1999; 65:680-3.
11. Moore PA, Belvedere O, Orr A et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999; 285:260-3.
12. Thompson JS, Bixler SA, Qian F et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001; 293:2108-11.
13. Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 2000; 10:785-8.
14. Cancro MP. Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol Rev 2004; 197:89-101.
15. O'Connor BP, Raman VS, Erickson LD et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004; 199:91-8.
16. Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 2003; 198:937-45.
17. Defrance T. Mature B cells: apoptosis checkpoints. Transplantation 2005; 79:S4-7.
18. Aggarwal S, Gupta A, Nagata S, Gupta S. Programmed cell death (apoptosis) in cord blood lymphocytes. J Clin Immunol 2005; 17:63-73.
19. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407:770-6.
20. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells. J Exp Med 2000; 191:883-90.
21. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002; 100:4537-43.
22. Moreaux J, Legouffe E, Jourdan E et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004; 103:3148-57.
23. Kern C, Cornuel JF, Billard C et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004; 103:679-88.
24. He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 2004; 172:3268-79.
25. Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 2000; 192:953-64.
26. Illera VA, Perandones CE, Stunz LL, Mower DA Jr, Ashman RF. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol 1993; 151:2965-73.
27. Wurster AL, Rodgers VL, White MF, Rothstein TL, Grusby MJ. Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J Biol Chem 1993; 277:27169-75.
28. Parry SL, Hasbold J, Holman M, Klaus GG. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol 1994; 152:2821-9.
29. Foote LC, Howard RG, Marshak-Rothstein A, Rothstein TL. IL-4 induces Fas resistance in B cells. J Immunol 1994; 157:2749-53.
30. Ghalbzouri A, Drenou B, Blancheteau V et al. An in vitro model of allogeneic stimulation of cord blood: induction of Fas independent apoptosis. Hum Immunol 1999; 60:598-607.
31. Szabolcs P, Park KD, Reese M, Marti L, Broadwater G, Kurtzberg J. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol 2003; 31:708-14.
32. Lin SJ, Cheng PJ, Huang YJ, Kuo ML. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry. Pediatr Allergy Immunol 2004; 15:79-85.
33. Allgaier B, Shi M, Luo D, Koenig JM. Spontaneous and Fas-mediated apoptosis are diminished in umbilical cord blood neutrophils compared with adult neutrophils. J Leukoc Biol 1998; 64 (3):331-6.
34. Koenig JM, Stegner JJ, Schmeck AC, Saxonhouse MA, Kenigsberg LE. Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness. Pediatr Res 2005; 57 (3):424-9.
35. Chesnut RW, Grey HM. Studies on the capacity of B cells to serve as antigen-presenting cells. J Immunol 1981; 126:1075-9.
36. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985; 314:537-9.